Your browser doesn't support javascript.
loading
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial.
Li, Jia; Xue, Zhixin; Wu, Zhenbiao; Bi, Liqi; Liu, Huaxiang; Wu, Lijun; Liu, Shengyun; Huang, Xiangyang; Wang, Yong; Zhang, Yan; Qi, Wufang; He, Lan; Dai, Lie; Sun, Lingyun; Li, Xiaomei; Shuai, Zongwen; Zhao, Yi; Wang, Yanyan; Xu, Jian; Zhang, Hao; Yu, Hao; Chen, Xiaoxiang; Bao, Chunde.
Affiliation
  • Li J; Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xue Z; Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wu Z; Department of Rheumatology and Immunology, Tangdu Hospital of the Fourth Military Medical University (Air Force Medical University), Xi'an, China.
  • Bi L; Department of Rheumatology and Immunology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Liu H; Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wu L; Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
  • Liu S; Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Huang X; Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Wang Y; Department of Traditional Chinese Medicine, Southwest Hospital, Army Medical University, Chongqing, China.
  • Zhang Y; Department of Rheumatology and Immunology, Tangdu Hospital of the Fourth Military Medical University (Air Force Medical University), Xi'an, China.
  • Qi W; Department of Rheumatology, the First Central Hospital, Tianjin, China.
  • He L; Department of Rheumatology and Immunology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Dai L; Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Sun L; Department of Rheumatology and Immunology, Institute of Translational Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Li X; Department of Rheumatology, Anhui Provincial Hospital, Hefei, China.
  • Shuai Z; Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhao Y; Department of Rheumatology and Allergy, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Wang Y; Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Xu J; Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Zhang H; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Yu H; Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Chen X; Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Xiaoxiang0721@126.com.
  • Bao C; Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. baochunde_1678@126.com.
Clin Rheumatol ; 41(10): 3005-3016, 2022 Oct.
Article de En | MEDLINE | ID: mdl-35676450
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pelvispondylite rhumatismale / Antirhumatismaux / Produits pharmaceutiques biosimilaires Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Adult / Humans Langue: En Journal: Clin Rheumatol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pelvispondylite rhumatismale / Antirhumatismaux / Produits pharmaceutiques biosimilaires Type d'étude: Clinical_trials Aspects: Patient_preference Limites: Adult / Humans Langue: En Journal: Clin Rheumatol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Allemagne